« Return to News | Drug Sponsors | R&D Trends

Warner to cut 500 jobs

Monday, April 18, 2011 01:28 PM

After losing patent protection on their osteoporosis drug Actonel, Ireland-based Warner Chilcott is restructuring its E.U. operations and plans to cut 500 jobs in the process, according to Fierce Pharma. Actonel brought in about 70% of Warner's sales in Western Europe in 2010, and the drug is up against generic competition.

Warner will restructure its business in Belgium, the Netherlands, France, Germany, Italy, Spain, Switzerland and the U.K.  However, commercial operations in the U.K. and Germany will not be affected, nor will its headquarters in Dublin.

The cutbacks will allow Warner to focus on the U.S., where it's launching an osteoporosis remedy and an oral contraceptive, Hans van Zoonen, president of Warner's European and international operations, said in a statement. "The restructuring initiative will allow us to focus on growth opportunities that match Warner Chilcott's key competitive strengths, including the launches of Atelvia and Lo Loestrin Fe in the United States," said van Zoonen, who's also president of global marketing.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.